Pharmaceutical Blockbusters: Paving the Way to Prime Performance

Apr 12, 2001, 01:00 ET from Best Practices, LLC

    CHAPEL HILL, N.C., April 12 /PRNewswire/ -- In the highly competitive
 pharmaceutical industry, companies race to develop competitive launch tactics,
 innovative marketing techniques and powerful sales forces.  In light of recent
 industry research, pharmaceutical benchmarking leader Best Practices, LLC,
 reports on the most powerful tactics that turn products into megabrands.
     According to Best Practices, LLC's benchmarking studies, available at
 www.BenchmarkingReports.com, companies develop innovative techniques to
 sustain market domination.  For instance, benchmarked companies are ramping up
 pre-launch marketing activities, leveraging thought leaders' sphere of
 influence, boosting marketing budgets and expanding sales forces.  Benchmark
 reports profile specific steps and corporate strategies for achieving these
 initiatives.
     The leading practices, managerial insights and benchmark metrics in Best
 Practices, LLC's reports are drawn from lessons learned interviews and
 benchmarking surveys with dozens of executives at leading pharmaceutical
 companies.  The insights contained in these pharmaceutical reports have helped
 pharmaceutical executives perfect their sales and marketing strategies, obtain
 more funding for their product marketing activities and turn their products
 into first-year blockbuster drugs.
     Some of the top-selling pharmaceutical reports include:
 
     * Best Practices Global Pharmaceutical Launches
     * Launching Pharmaceutical Megabrands: Best Practices in Marketing
       Blockbusters
     * Best Practices in Pharmaceutical Alliances and Co-Promotions
     * Thought Leader Relationships: Building the Business
     * Best Practices in Pharmaceutical Sales
 
     "Our research has found that many top pharmaceutical companies excel in
 certain areas, but no one company has all the answers," says BPLLC senior
 project manager David Wang.  "The companies that successfully implement a
 combination of top companies' best practices stand to reap billion-dollar
 profits."
     All of Best Practices, LLC's reports are available at
 http://www.BenchmarkingReports.com.  For more information about these
 pharmaceutical benchmarking studies, contact Alison Maguire at (919) 403-0251
 extension 250 or amaguire@best-in-class.com.
 
     ABOUT BEST PRACTICES, LLC
     Best Practices, LLC conducts work based on the principle that
 organizations can chart a course to superior economic performance by studying
 top companies' best business practices, operating tactics, and winning
 strategies.  For more information about Best Practices, LLC, call 919-403-0251
 or visit the corporate website at http://www.best-in-class.com/
 
 

SOURCE Best Practices, LLC
    CHAPEL HILL, N.C., April 12 /PRNewswire/ -- In the highly competitive
 pharmaceutical industry, companies race to develop competitive launch tactics,
 innovative marketing techniques and powerful sales forces.  In light of recent
 industry research, pharmaceutical benchmarking leader Best Practices, LLC,
 reports on the most powerful tactics that turn products into megabrands.
     According to Best Practices, LLC's benchmarking studies, available at
 www.BenchmarkingReports.com, companies develop innovative techniques to
 sustain market domination.  For instance, benchmarked companies are ramping up
 pre-launch marketing activities, leveraging thought leaders' sphere of
 influence, boosting marketing budgets and expanding sales forces.  Benchmark
 reports profile specific steps and corporate strategies for achieving these
 initiatives.
     The leading practices, managerial insights and benchmark metrics in Best
 Practices, LLC's reports are drawn from lessons learned interviews and
 benchmarking surveys with dozens of executives at leading pharmaceutical
 companies.  The insights contained in these pharmaceutical reports have helped
 pharmaceutical executives perfect their sales and marketing strategies, obtain
 more funding for their product marketing activities and turn their products
 into first-year blockbuster drugs.
     Some of the top-selling pharmaceutical reports include:
 
     * Best Practices Global Pharmaceutical Launches
     * Launching Pharmaceutical Megabrands: Best Practices in Marketing
       Blockbusters
     * Best Practices in Pharmaceutical Alliances and Co-Promotions
     * Thought Leader Relationships: Building the Business
     * Best Practices in Pharmaceutical Sales
 
     "Our research has found that many top pharmaceutical companies excel in
 certain areas, but no one company has all the answers," says BPLLC senior
 project manager David Wang.  "The companies that successfully implement a
 combination of top companies' best practices stand to reap billion-dollar
 profits."
     All of Best Practices, LLC's reports are available at
 http://www.BenchmarkingReports.com.  For more information about these
 pharmaceutical benchmarking studies, contact Alison Maguire at (919) 403-0251
 extension 250 or amaguire@best-in-class.com.
 
     ABOUT BEST PRACTICES, LLC
     Best Practices, LLC conducts work based on the principle that
 organizations can chart a course to superior economic performance by studying
 top companies' best business practices, operating tactics, and winning
 strategies.  For more information about Best Practices, LLC, call 919-403-0251
 or visit the corporate website at http://www.best-in-class.com/
 
 SOURCE  Best Practices, LLC